Current Neuro-Oncology




Volume 12 Number 10
31 October 2010




Home > Publications > Current Neuro-Oncology > Volume 12, Year 2010 > Number 10, 31 October






Bogdahn U, Hau P, Stockhammer G, Venkataramana NK, Mahapatra AK, Suri A, Balasubramaniam A, Nair S, Oliushine V, Parfenov V, Poverennova I, Zaaroor M, Jachimczak P, Ludwig S, Schmaus S, Heinrichs H, Schlingensiepen KH; Trabedersen Glioma Study Group.
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.
Neuro Oncol. 2010 Oct 27. 2011;13(1):132-42. doi: 10.1093/neuonc/noq142
. PMID: 20980335. Phase 2b trial.